A detailed guide to clinical research sites across Venezuela — from Caracas to Maracaibo — covering hospital infrastructure, investigator qualifications, and site selection criteria for international sponsors.
July 3, 2026
13
min read
By
bioaccess® Editorial Team
clinical research sites Venezuela
Venezuela hospitals clinical trials
GCP-trained investigators Venezuela
**Key Takeaways**
- • 4 major cities: Caracas, Valencia, Maracaibo, and Barquisimeto offer clinical research infrastructure
- • physician capacity confirmed per protocol with many GCP-trained and internationally experienced
- • Private hospital sector remains fully operational with modern equipment
- • bioaccess® has investigators confirmed for the proposed protocol across all major cities
- • Multi-site and multi-country trials supported through bioaccess® network
**The short answer**
Venezuela’s clinical research infrastructure concentrates in four cities — Caracas, Valencia, Maracaibo, and Barquisimeto — anchored by a fully operational private hospital sector with modern equipment. The country has physician capacity confirmed per protocol, many GCP-trained and internationally experienced, and bioaccess® maintains investigators confirmed for the proposed protocol across all four hubs. Site selection typically runs in phase 2 of the study-specific startup timeline, in parallel with regulatory strategy.
Where is Venezuela's clinical research infrastructure located?
Venezuela's clinical research landscape is anchored by a robust private hospital sector that has maintained high-quality infrastructure despite economic challenges. For sponsors evaluating first-in-human clinical trials in Venezuela, the country offers well-equipped facilities with experienced investigators across multiple therapeutic areas.
bioaccess®, as the a first-in-human CRO founded in 2010, has mapped the country's clinical research capabilities and identified top-tier sites across four major cities.
Caracas: the capital hub
Caracas, Venezuela's capital and largest city, is the primary center for clinical research in the country. The city offers:
- Largest concentration of private hospitals and specialty clinics
- Teaching hospitals with active research programs
- Access to specialists across all therapeutic areas
- International airport (Simón Bolívar) for sponsor and monitor travel
- Concentration of pharmaceutical companies and regulatory agency offices
Valencia: industrial and medical center
Valencia, Venezuela's third-largest city and a major industrial center, offers a growing clinical research infrastructure:
- Strong private hospital network with modern diagnostic capabilities
- Large patient population with diverse disease profiles
- Well-connected by highway to Caracas (2 hours) for monitoring visits
- University medical centers with research-oriented faculty
- Lower operational costs than Caracas while maintaining quality
Maracaibo: western Venezuela
Maracaibo, the capital of Zulia state and Venezuela's second-largest city, serves as the western hub for clinical research:
- Major university hospital (Hospital Universitario de Maracaibo) with research tradition
- Large patient catchment area covering western Venezuela
- Specialty expertise in cardiovascular, metabolic, and tropical diseases
- International airport for direct travel access
- Diverse patient demographics for enrollment diversity
Barquisimeto: central-western hub
Barquisimeto, Venezuela's fourth-largest city, offers additional site options:
- Strong medical infrastructure for a mid-sized city
- University-affiliated hospitals with research capacity
- Strategic geographic location in central-western Venezuela
- Treatment-naïve patient populations in surrounding areas
- Cost-effective site option for multi-center studies
What qualifications and capabilities do Venezuelan investigators have?
Venezuelan investigators bring strong qualifications to clinical research:
| Qualification | Availability | Notes |
|---|---|---|
| MD with specialty training | High | Strong medical education system |
| ICH-GCP certification | Moderate-High | bioaccess® provides training as needed |
| Prior clinical trial experience | Moderate | Growing with bioaccess® operations |
| International training/fellowship | Moderate | Many trained in the US |
| Bilingual (Spanish-English) | Moderate-High | Facilitates sponsor communication |
| Sub-specialty expertise | High | Available across therapeutic areas |
How should sponsors select sites in Venezuela?
bioaccess® evaluates potential clinical trial sites in Venezuela using a comprehensive set of criteria:
- Investigator expertise: therapeutic area experience and GCP training
- Patient access: enrollment potential based on disease prevalence and catchment area
- Facility capabilities: laboratory, pharmacy, imaging, and specialty equipment
- Regulatory compliance: clean inspection history and proper documentation systems
- Staff availability: dedicated study coordinators and sub-investigators
- Geographic accessibility: monitoring visit logistics and travel feasibility
- IRB/ethics committee: established, responsive institutional ethics committee
A city list is not a feasibility result. A protocol-specific country assessment has to confirm sites, investigators and recruitment for the proposed study.
Is GCP-trained staff available in Venezuela?
bioaccess® ensures all investigators and study staff in its Venezuelan network meet international GCP standards. Our training program includes:
- ICH-GCP E6(R2) certification for all PIs and sub-investigators
- Protocol-specific training sessions for each new study
- eCRF/EDC system training for data entry staff
- Safety reporting and pharmacovigilance training
- Ongoing GCP refresher courses and updates
How does bioaccess®'s investigator network help sponsors?
bioaccess® has built a investigators confirmed for the proposed protocol across Venezuela's major cities, enabling rapid site identification and activation for sponsors. Our network includes specialists in cardiology, oncology, neurology, dermatology, ophthalmology, orthopedics, and rare diseases.
**Need sites in Venezuela?**
bioaccess® can identify and activate clinical trial sites in Venezuela within weeks. Contact us for a site feasibility assessment, or explore our site search and selection services.
Frequently asked questions
Planning your next step in Venezuela?
Explore clinical-trial planning for protocol-specific research questions, or medical-device registration and market access for SACS documentation and local registration arrangements. These are separate regulatory workstreams.
Get your FIH roadmap for Venezuela
bioaccess® has the sites, investigators, and infrastructure to support your clinical trial in Venezuela.